BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36698530)

  • 1. Diagnostic value of
    Zheng F; Wanjun X; Shuaishuai W; Tong W; Lue Z
    Med Int (Lond); 2021; 1(5):23. PubMed ID: 36698530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of incidental focal colorectal uptake by analysis of fluorine-18 fluorodeoxyglucose positron emission tomography parameters.
    Lee H; Hwang KH; Kwon KA
    World J Clin Cases; 2022 Jun; 10(17):5634-5645. PubMed ID: 35979099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters.
    Lee H; Chung YS; Lee JH; Lee KY; Hwang KH
    World J Clin Cases; 2022 Jan; 10(1):155-165. PubMed ID: 35071515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical value of texture analysis of dual-time-point
    Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
    Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma.
    Shi H; Yuan Z; Yuan Z; Yang C; Zhang J; Shou Y; Zhang W; Ping Z; Gao X; Liu S
    Korean J Radiol; 2018; 19(2):342-351. PubMed ID: 29520193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Mediastinal Tumors Using SUV
    Morita T; Tatsumi M; Ishibashi M; Isohashi K; Kato H; Honda O; Shimosegawa E; Tomiyama N; Hatazawa J
    Asia Ocean J Nucl Med Biol; 2017; 5(1):22-29. PubMed ID: 28840135
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhou W; Wen J; Hua F; Xu W; Lu X; Yin B; Geng D; Guan Y
    Eur J Radiol; 2018 Jul; 104():26-32. PubMed ID: 29857862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
    Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
    Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of 2-deoxy-2-fluorine-18-fluoro-D-glucose positron emission tomography/computed tomography parameters for MYCN amplification in high-risk neuroblastoma.
    Li S; Liu J; Wang G; Feng L; Yang X; Kan Y; Wang W; Yang J
    Eur J Radiol; 2024 Jan; 170():111243. PubMed ID: 38043380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
    Chen B; Feng H; Xie J; Li C; Zhang Y; Wang S
    BMC Med Imaging; 2020 Jul; 20(1):85. PubMed ID: 32711449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of (18)F-FDG PET/CT in the Detection of Ovarian Malignancy.
    Park T; Lee S; Park S; Lee E; Pahk K; Rhee S; Cho J; Kim C; Eo JS; Choe JG; Kim S
    Nucl Med Mol Imaging; 2015 Mar; 49(1):42-51. PubMed ID: 25774237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of 18F-FDG PET/CT in discriminating between benign and malignant lesions of the ribs.
    Choi S; Kim YI; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
    Medicine (Baltimore); 2022 Jul; 101(27):e29867. PubMed ID: 35801734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical value of baseline
    Reyes Marlés RH; Navarro Fernández JL; Puertas García-Sandoval JP; Santonja Medina F; Mohamed Salem L; Frutos Esteban L; Contreras Gutiérrez JF; Castellón Sánchez MI; Ruiz Merino G; Claver Valderas MA
    Eur J Hybrid Imaging; 2021 Sep; 5(1):16. PubMed ID: 34476632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of multiple dual-phase
    Liu X; Zou Q; Sun Y; Liu H; Cailiang G
    Heliyon; 2023 Oct; 9(10):e20180. PubMed ID: 37767476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of Metabolic Parameters Derived From
    Liu H; Ye Z; Yang T; Xie H; Duan T; Li M; Wu M; Song B
    Front Immunol; 2021; 12():724464. PubMed ID: 34512653
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Qin C; Shao F; Hu F; Song W; Song Y; Guo J; Lan X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1083-1093. PubMed ID: 31807883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.
    Kitao T; Shiga T; Hirata K; Sekizawa M; Takei T; Yamashiro K; Tamaki N
    Ann Nucl Med; 2019 Jan; 33(1):22-31. PubMed ID: 30196378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.